Arif Bilal
SEC insider (Form 3/4/5 filer). CIK 0001959750. Chief Operations Officer at KalVista Pharmaceuticals, Inc. (KALV) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in FRAMINGHAM, MA.
Companies Arif Bilal has filed insider reports for
- KalVista Pharmaceuticals, Inc. (KALV): Officer, Chief Operations Officer
- Sarepta Therapeutics, Inc. (SRPT): Officer, Chief Tech Ops Officer
Arif Bilal
CIK: 0001959750
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
100K shares- - Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirectRestricted Stock Unit
49K shares- - Jan 16, 2026KALV
KalVista Pharmaceuticals, Inc.
AwardDirectRestricted Stock Unit
49K shares- - Oct 8, 2025KALV
KalVista Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
100K shares- - Aug 5, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirectPerformance Stock Units
6.3K shares- - Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
Tax PaymentDirect523 shares at avg. $100.13$52K - Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect8.3K shares- - Mar 7, 2025SRPT
Sarepta Therapeutics, Inc.
Tax PaymentDirect8.5K shares at avg. $103.70$884K - Mar 7, 2025SRPT
Sarepta Therapeutics, Inc.
Tax PaymentDirect508 shares at avg. $103.70$53K - Mar 6, 2025SRPT
Sarepta Therapeutics, Inc.
ExerciseDirect17.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  KALV KalVista Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | Disposition Restricted Stock Unit | 49,000 | - | - | Direct |
| Jan 16, 2026 | KALV KalVista Pharmaceuticals, Inc. | Award Restricted Stock Unit | 49,000 | - | - | Direct |
| Oct 8, 2025 | KALV KalVista Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 100,000 | - | - | Direct |
| Aug 5, 2025 |  SRPT Sarepta Therapeutics, Inc. | Award Performance Stock Units | 6,250 | - | - | Direct |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | Tax Payment | 523 | $100.13 | $52,368 | Direct |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 8,276 | - | - | Direct |
| Mar 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Tax Payment | 8,527 | $103.70 | $884,250 | Direct |
| Mar 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Tax Payment | 508 | $103.70 | $52,680 | Direct |
| Mar 6, 2025 | SRPT Sarepta Therapeutics, Inc. | Exercise | 17,500 | - | - | Direct |
1-10 of 14 transactions